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In Brief
Andreone et al. revealed a key mechanism that explains how the suppression of transcytosis occurs to control BBB permeability. They discovered a single pathway revealing that the lipids transported by Mfsd2a control the formation of caveolae and therefore BBB integrity.
SUMMARY
The blood-brain barrier (BBB) provides a constant homeostatic brain environment that is essential for proper neural function. An unusually low rate of vesicular transport (transcytosis) has been identified as one of the two unique properties of CNS endothelial cells, relative to peripheral endothelial cells, that maintain the restrictive quality of the BBB. However, it is not known how this low rate of transcytosis is achieved. Here we provide a mechanism whereby the regulation of CNS endothelial cell lipid composition specifically inhibits the caveolae-mediated transcytotic route readily used in the periphery. An unbiased lipidomic analysis reveals significant differences in endothelial cell lipid signatures from the CNS and periphery, which underlie a suppression of caveolae vesicle formation and trafficking in brain endothelial cells. Furthermore, lipids transported by Mfsd2a establish a unique lipid environment that inhibits caveolae vesicle formation in CNS endothelial cells to suppress transcytosis and ensure BBB integrity.
INTRODUCTION
Vascular beds throughout the body have developed structural and functional heterogeneity to meet the demands of particular organs (Aird, 2007) . The CNS requires a constant homeostatic microenvironment that is free of blood-borne toxins, allowing for proper synaptic transmission and information processing. The endothelial cells that line the walls of CNS blood vessels form a continuous, non-fenestrated vasculature. These cells constitute the blood-brain barrier (BBB), which regulates solute flux between blood circulation and the brain parenchyma (Andreone et al., 2015; Zhao et al., 2015) . BBB disruption has been implicated in the pathogenesis of neurodegenerative diseases (Zhao et al., 2015; Zlokovic, 2008) . Since BBB functionality is essential for normal brain activity, the impermeable nature of the BBB prevents brain uptake of most neurotherapeutic agents (Pardridge, 2012 ). This signifies a major obstacle to drug treatment of CNS diseases.
Pioneering electron microscopy (EM) work by Brightman, Reese, and Karnovsky (Brightman and Reese, 1969; Reese and Karnovsky, 1967) identified two structural features of CNS endothelial cells that underlie the restrictive properties of the BBB. First, specialized tight junctions prevent the paracellular passage of water-soluble molecules from the circulatory system to the brain parenchyma. Second, CNS endothelial cells exhibit unusually low levels of vesicle trafficking, a phenomenon that has generally been assumed to limit transcellular transport (transcytosis). While conventional wisdom has emphasized the importance of tight junctions, recent advances have highlighted the regulation of transcytosis as a crucial factor in limiting BBB permeability under physiological conditions and after pathological assaults (Armulik et al., 2010; Ben-Zvi et al., 2014; Daneman et al., 2010b; Knowland et al., 2014) . However, the mechanism by which the suppression of transcytosis is achieved in CNS endothelial cells is completely unknown. An understanding of how transcytosis is regulated to maintain BBB integrity is not only fundamental to understanding BBB function, but also to developing therapeutic strategies to transiently open the BBB for CNS drug delivery.
Transcytotic pathways in epithelial and endothelial cells fall into two categories: clathrin mediated and non-clathrin mediated (Mayor et al., 2014) . The mechanisms of clathrin-mediated vesicle trafficking are the most studied; these studies have identified the transferrin receptor-mediated transcytosis of iron as a key pathway that has been targeted for manipulation at the BBB for drug delivery (Bien-Ly et al., 2014; Niewoehner et al., 2014) . Non-clathrin-mediated vesicle trafficking pathways utilize a broad range of large-and small-scale membrane invaginations that harness diverse cellular machinery, including dynamin, coat proteins, small GTPases, and RhoGAP proteins (Mayor et al., 2014) . Among the many non-clathrin-mediated pathways, caveolae-mediated vesicle trafficking predominates as a transcytotic route used in the endothelial cells of peripheral organs, including heart and lung, to transport solutes from the blood to underlying tissue (Oh et al., 2007 (Oh et al., , 2014 Predescu et al., 1997; Schubert et al., 2001 ). Caveolae are 50-100 nm invaginations in the plasma membrane (Bastiani and Parton, 2010) . The plasma membrane domains that form caveolae vesicles are highly ordered and enriched in saturated phospholipids, sphingolipids, ethanolamine plasmalogens (PE-p), and cholesterol (Parton and del Pozo, 2013; Pike et al., 2002) . Additionally, the formation of caveolae vesicles requires the activity of both caveolin coat proteins and cytosolic adaptor proteins belonging to the cavin family (Bastiani and Parton, 2010) . Although diverse functions have been identified for caveolae, their physiological role in different cell types and tissues is not fully understood (Cheng and Nichols, 2016) . Previously, we established that major facilitator superfamily domain containing 2a (Mfsd2a) is a key regulator for BBB function (Ben-Zvi et al., 2014) . Mfsd2a is specifically expressed in CNS endothelial cells. Genetic ablation of Mfsd2a in mice results in a leaky BBB, as extravasation of several intravenously injected tracers, including 10 and 70 kD dextrans, NHS-biotin, and horseradish peroxidase (HRP), into the brain parenchyma is observed in Mfsd2a À/À mice from embryonic stages through adulthood.
EM examination of brain endothelial cells from Mfsd2a
À/À mice reveals increased transcytosis, as the intracellular vesicle number significantly increases. Additionally, HRP-injected mutants exhibit HRP-filled vesicles invaginating from the luminal plasma membrane, within the endothelial cell cytoplasm, and exocytosing at the abluminal plasma membrane. While these Mfsd2a À/À mice have transcytotic defects, their tight junctions are normal. These findings demonstrate that Mfsd2a is specifically required to regulate transcytosis in CNS endothelial cells of the BBB and that the tracer extravasation observed in Mfsd2a À/À mice is solely due to increased levels of transcytotic vesicles within these cells. Therefore, Mfsd2a may serve as an ideal molecular handle to understand the mechanism by which transcytosis is regulated at the BBB. There are several potential mechanisms whereby Mfsd2a regulates transcytosis in CNS endothelial cells, such as affecting transcytotic machinery via direct or indirect physical interactions or via controlling plasma membrane tension. Interestingly, in addition to its role in BBB function, Mfsd2a has been identified as a lipid transporter at the luminal plasma membrane of CNS endothelial cells to deliver the essential omega-3 fatty acid docosahexaenoic acid (DHA) into the brain (Nguyen et al., 2014) . However, how DHA travels from the CNS endothelial cell plasma membrane to neurons is undetermined. DHA is heavily implicated in brain development (Innis, 2007) , and, indeed, Mfsd2a À/À mice have reduced total brain levels of DHA species and exhibit microcephaly (Nguyen et al., 2014) . Therefore, although there is no existing example of lipids in endothelial cells playing a role in BBB function, examining if Mfsd2a's lipid transport function is related to BBB integrity will help narrow down the possible mechanisms of Mfsd2a-mediated regulation of transcytosis.
In this study, we show how transcytosis is suppressed in CNS endothelial cells to ensure proper BBB function by focusing on Mfsd2a. Using a combination of mouse genetics, lipidomic mass spectrometry, and EM analysis, we elucidate a pathway underlying the cellular mechanism of BBB function: lipids transported by Mfsd2a create a unique lipid composition of CNS endothelial cells that inhibits specifically caveolae-mediated transcytosis to maintain BBB integrity. Moreover, unbiased lipidomic analyses reveal that the lipid signatures of endothelial cells from the CNS and the periphery exhibit significant differences, which underlie the suppression of caveolae vesicle formation and trafficking in brain endothelial cells. Thus, this study establishes that lipid composition of CNS endothelial cells serves as a key new player in the regulation of transcytosis and barrier permeability.
RESULTS

Mfsd2a
Cell-Autonomously Suppresses Vesicular Pit Formation and Cargo Uptake at the Plasma Membrane To understand how transcytosis is regulated at the BBB, we first asked whether Mfsd2a is sufficient to suppress endocytic vesicle formation, the first step of all transcytotic pathways. Mfsd2a was expressed using lentivirus with high efficiency in the immortalized mouse brain endothelial cell line bEnd.3, in which endogenous Mfsd2a expression was not detectable (Figure 1A) . Exogenous expression of Mfsd2a displayed cell-surface localization in bEnd.3 cells ( Figure 1B) , as well as cytoplasmic puncta, as seen in other cell lines (Nguyen et al., 2014; Reiling et al., 2011) . EM revealed a reduction in the number of apical (analogous to luminal) micro-invaginations (pits) in cells expressing Mfsd2a compared to mock-infected control cells ( Figures  1C-1E ; Table S4A ). A similar reduction in vesicular pit number was observed in a human pancreatic cancer cell line, PANC-1, stably transfected with human MFSD2A-GFP, compared to control cells stably transfected with GFP alone (Figures 1F-1H ; Table S4A ). These findings suggest that Mfsd2a expression is sufficient to inhibit vesicle formation.
To further assess whether Mfsd2a can directly inhibit cargo uptake, we next loaded confluent bEnd.3 cell cultures with a fluorescent cholera toxin subunit B (CTB) tracer (Figures 1I and 1J) . Cells that express mouse Mfsd2a-GFP exhibited a 50% reduction in CTB uptake, as quantified by fluorescence intensity ( Figure 1L ), compared to cells that express GFP alone (Figure 1K) . Use of the GFP-tagged constructs did not affect Mfsd2a protein localization (Reiling et al., 2011 ) (data not shown) and allowed for identification of positively transfected cells without quenching of the CTB fluorescence due to immunostaining protocol. These gain-of-function results are consistent with previous (K and L) CTB uptake quantified as corrected total cell fluorescence (CTCF) per GFP transfected (K) or Mfsd2a-GFP transfected (L) cell compared to CTCF of at least two untransfected cells per image. n = 4; at least 15 transfected cells per experiment. All data are mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01 (Student's t test). See also Table S4. in vivo loss-of-function data (Ben-Zvi et al., 2014) and together demonstrate that Mfsd2a is necessary and sufficient for the suppression of vesicle formation and cargo uptake, cellular processes underlying transcytosis. Furthermore, they suggest that Mfsd2a acts via a direct mechanism to suppress CNS endothelial cell transcytosis in a cell-autonomous manner.
Mfsd2a Lipid Transport Function Is Required for Suppression of Transcytosis and BBB Integrity
To investigate how Mfsd2a may act directly at the CNS endothelial cell plasma membrane to regulate vesicle trafficking, we first asked whether the reported lipid transport function of Mfsd2a is required to suppress transcytosis. Although there is no known role of lipids in CNS endothelial cells for BBB function, answering this question will help to narrow down and pinpoint Mfsd2a's precise mechanism of action. Specifically to address this question, we generated a transporter-dead Mfsd2a knockin mouse as an in vivo tool. Asp96 is a conserved amino acid required for the cation binding that is crucial for transporter activity in MFS family members (Ethayathulla et al., 2014) , and the D96A aspartic acid to alanine point mutation abolishes Mfsd2a transport function in vitro (Nguyen et al., 2014; Reiling et al., 2011) . A mouse line harboring the Mfsd2a D96A mutation in the endogenous Mfsd2a locus was generated via CRISPR/Cas9 gene editing. Specifically, one amino acid change resulting in the D96A missense mutation was introduced into exon 3 of Mfsd2a (Figures 2A, S1B , and S1C To determine whether the observed increased transcytosis results in BBB leakage in Mfsd2a D96A mutants, we performed intravenous injection of fluorescent tracer at P4 and examined tracer localization as a metric of BBB integrity. We chose 10 kD dextran tracer for analysis, as robust extravasation of this tracer was previously observed in Mfsd2a À/À mice (Ben-Zvi et al., 2014).
While tracer was completely confined within the vasculature of Mfsd2a +/+ littermate control animals ( Figure 3M ), tracer extravasation was observed throughout the brain of Mfsd2a D96A mutants ( Figure 3N ), with tracer diffused into the brain parenchyma and taken up by non-vascular cells. Permeability index quantification (defined as area of tracer/area of vessels) revealed a statistically significant increase of BBB leakage in Mfsd2a D96A mutants compared to Mfsd2a +/+ controls ( Figure 3O ). BBB leakage in Mfsd2a D96A mutants persisted into adulthood, as HRP tracer extravasation into the forebrain parenchyma was observed at P90 (Figures S3A and S3B) . Taken together, these data demonstrate that BBB leakage occurs in Mfsd2a D96A mice via increased transcytosis, similar to Mfsd2a À/À mice.
Furthermore, they strongly implicate the lipid transport function of Mfsd2a in the suppression of vesicle trafficking.
Brain Capillaries Possess a Lipid Signature Underlying Suppression of Caveolae
Our results demonstrate that Mfsd2a cell-autonomously suppresses vesicle trafficking via a lipid transport-dependent mechanism. This raises the possibility that lipid transport directly affects the membrane lipid composition of CNS endothelial cells, which in turn may result in the suppression of transcytosis at the BBB. To further understand the link between lipids and vesicle trafficking, we next asked whether the lipid composition of CNS endothelial cells, a previously unexplored facet of BBB function, shows any differences compared to peripheral endothelial cells.
To investigate this possibility, we performed lipidomic mass spectrometry analysis on acutely isolated capillaries from brain and lung of wild-type mice at P4. Lung vasculature does not possess the restrictive barrier properties of CNS vasculature, and lung endothelial cells are enriched in transcytotic vesicles, which have been shown to transport cargo from the circulation to the lung parenchyma (Ghitescu et al., 1986; Oh et al., 2007; Schubert et al., 2001 ). Western blot analysis showed that this capillary preparation is highly enriched in endothelial cells in both brain and lung, indicated by an abundance of VE-cadherin protein compared to total tissue lysate ( Figure S4B ). Residual pericytes were present in both brain and lung capillary preparations, and, importantly, the brain capillary preparation was free of both neurons (NeuN) and astrocyte endfeet (Aquaporin-4) (Figures S4A and S4B) . Lipidomic analysis revealed that although most lipid species were found at similar levels in isolated brain and lung capillaries, significant differences in several lipid species were observed (Figures 4A and S4C ; Table S3 ). Remarkably, one of the most Tables S1 and S2. significantly enriched lipid populations in brain capillaries was DHA-containing phospholipid species in lysophosphatidylethanolamine (LPE), phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylserine (PS) subclasses, ranging from 1.9-to 5.1-fold enrichment ( Figure 4B ). Significant enrichment of a few non-DHA-containing lipids, such as C34:0 PC and C38:4 PE, was also observed in brain capillaries ( Figure 4A ). On the other hand, modest decreases in several PE-p species Table S4. were observed in brain capillaries compared to lung capillaries ( Figure S5A ). Although both the acutely isolated brain and lung capillary preparations retained residual pericytes, it unlikely that these cells contribute to the observed differences in lipid signature, for pericytes do not express Mfsd2a (Ben-Zvi et al., 2014) , the only known DHA transporter in the brain; there is no evidence that pericytes are able to synthesize DHA de novo; and both brain and lung capillary preparations were highly enriched in endothelial cells. Notably, lung endothelial cells have abundant caveolae vesicles that can act as transcytotic carriers (Ghitescu et al., 1986; Oh et al., 2007; Schubert et al., 2001) . The formation and functionality of caveolae membrane domains can be affected by plasma membrane lipid composition (Lingwood and Simons, 2010; Parton and del Pozo, 2013) . In particular, DHA is a highly unsaturated fatty acid that disrupts liquid-ordered caveolae domains, normally enriched in saturated phospholipids, sphingolipids, PE-p species, and cholesterol. DHA displaces Caveolin-1 (Cav-1), a coat protein of the caveolin family that is obligatory for caveolae vesicle formation, from the plasma membrane. Thus, enrichment of DHA in the plasma membrane renders caveolae membrane domains less capable of forming caveolae vesicles (Chen et al., 2007; Li et al., 2007; Ma et al., 2004) . Therefore, the lipid composition of brain capillaries enriched in DHA species and low in PE-p species may reflect a plasma membrane microenvironment in CNS endothelial cells that is unfavorable for the assembly of functional caveolae domains and subsequent vesicle formation. Together, these analyses reveal significant differences in the lipid signature of BBB-containing brain capillaries versus non-BBB-containing lung capillaries, some of which may contribute to the suppression of transcytosis at the BBB by inhibiting caveolae vesicle formation and trafficking in CNS endothelial cells.
Significantly reduced levels of several triglycerides (TAGs) and cholesteryl ester (CE) species were observed in brain capillaries versus lung capillaries ( Figures S5B and S5C ). TAGs and CEs are stored in intracellular lipid droplets (Guo et al., 2009) , and both in vitro and in vivo evidence suggests that the storage of these lipids depends on caveolae vesicle trafficking (Cohen et al., 2004; Martin and Parton, 2005; Pol et al., 2004) . Therefore, low levels of TAGs and CEs in brain capillaries may reflect a low level of caveolae trafficking. Together these observations raise the possibility that caveolae vesicles may be the subtype increased in CNS endothelial cells that accounts for the leaky BBB in Mfsd2a À/À mice. ( Figure 5I ; Table S4C ). These data suggest that caveolae vesicle trafficking is upregulated in mice lacking Mfsd2a, and that Mfsd2a may normally act to suppress caveolae-mediated transcytosis in CNS endothelial cells.
Caveolae-Mediated Transcytosis Is Specifically Suppressed Downstream of Mfsd2a Function at the BBB In Vivo
To directly test the idea that the caveolae-mediated transcytosis pathway is suppressed downstream of Mfsd2a function at the BBB, we performed a genetic rescue experiment by crossing Mfsd2a À/À with Cav-1 À/À mice, as Cav-1 is obligatory for caveolae formation. While Cav-1 À/À mice are viable, they are unable to form caveolae vesicle structures and display defects in cargo uptake in vivo Schubert et al., 2001 Table S4D ). Therefore, the caveolae-mediated transcytosis pathway is the one that is normally suppressed by Mfsd2a. In contrast, no significant difference in the density of clathrincoated pits, identified under EM by the presence of an electron-dense clathrin coat ( Figure S6A ), was observed in
; Cav-1 À/À , or Mfsd2a D96A mutants compared to their littermate controls (Figures S6B-S6E ; Tables S4E and S4F ). Together, these data demonstrate that Mfsd2a acts upstream of Cav-1 specifically to suppress the caveolae vesicle trafficking pathway at the BBB.
Finally, we asked if caveolae-mediated transcytosis is required for regulating BBB permeability by examining whether genetic loss of Cav-1 is able to rescue the BBB leakage observed in the brains of Mfsd2a À/À mice. To evaluate BBB permeability, we again examined 10 kD dextran tracer localization in the brain after intravenous injection at P5. Tracer was confined within the brain vasculature of Mfsd2a +/+ ; Cav-1 +/+ wild-type and Figures 6N and 6O ). This observed rescue of BBB leakage was also evidenced at adult stages, as extravasation of HRP tracer into the forebrain parenchyma was observed in Mfsd2a À/À ; Cav-1 +/+ single knockouts ( Figure S3D) ; Cav-1 À/À double knockouts were able to rescue the BBB defects seen in Mfsd2a À/À mice, they were unable to rescue the microcephaly phenotype (Figure 7) . Thus, the caveolae pathway downstream of Mfsd2a in CNS endothelial cells specifically controls transcytosis and BBB function, but is not required for Mfsd2a-mediated delivery of DHA into the brain parenchyma for proper brain development. Our analysis of the Mfsd2a D96A mouse, together with the comparative brain and lung capillary lipidomic profiling, indicates that the suppression of the caveolae pathway requires the transport of lipids, notably DHA-containing phospholipids, by Mfsd2a to regulate CNS endothelial cell plasma membrane composition and inhibit caveolae vesicle formation.
DISCUSSION
While it was observed nearly 50 years ago that CNS endothelial cells exhibit unusually low levels of transcytotic vesicles (Brightman and Reese, 1969; Reese and Karnovsky, 1967) , it has remained poorly understood whether this low rate of transcytosis is important for BBB function, what type of vesicles are involved, and how vesicle formation and transcytosis are maintained at low levels in brain endothelial cells. In this study, we reveal that the unique membrane lipid composition of CNS endothelial cells regulates BBB permeability by suppressing caveolae-mediated transcytosis. Our findings support a model in which Mfsd2a-mediated transport of DHA controls the luminal plasma membrane DHA lipid composition of CNS endothelial cells such that it actively prevents the formation of functional caveolae membrane domains (Figures 8A and 8B) . Thus, unlike lung endothelial cells, which have low levels of DHA and display high levels of transcytotic caveolae vesicles, Mfsd2a-mediated lipid transport into CNS endothelial cells renders them less capable of forming caveolae vesicles to act as transcytotic carriers. As a result, the BBB is functional. Together, these findings uncover a mechanism for the suppression of transcytosis in CNS endothelial cells to maintain BBB integrity, and reveal an essential role for the precise control of membrane lipid composition in the regulation of BBB permeability. See also Figures S3, S6 , and S7 and Table S4 . 
The Unique Lipid Composition of CNS Endothelial Cells Underlies BBB Function
Although the field has successfully identified several key gene and protein regulators for BBB function (Ben-Zvi et al., 2014; Chow and Gu, 2015; Daneman et al., 2010a; Junge et al., 2009; Liebner et al., 2008; Sohet et al., 2015; Tam et al., 2012; Zhou et al., 2014) , the question of whether lipids can regulate BBB function has yet to be examined. Our demonstration of the in vivo requirement of the lipid transport function of Mfsd2a for the suppression of transcytosis and BBB permeability, coupled with our result of lipidomic profiling of capillaries from brain versus lung, reveals lipid composition of CNS endothelial cells as a key regulator for BBB function. Previous work on Mfsd2a has focused on the deleterious consequences of decreased DHA levels in brain parenchymal cells, such as behavioral abnormalities and microcephaly (Alakbarzade et al., 2015; Guemez-Gamboa et al., 2015; Nguyen et al., 2014) . Our results demonstrate an additional direct functional role of DHA transport at the CNS endothelial cell luminal plasma membrane, the site of Mfsd2a expression in the brain, for suppression of caveolae transcytosis and maintenance of BBB integrity. Besides DHA species, C34:0 PC and C38:4 PE are also significantly enriched in brain capillaries relative to lung capillaries, and their function at the BBB remains to be determined. Together, our Mfsd2a D96A mouse model and brain versus lung lipidomic profiling illuminate a previously unknown role of CNS endothelial cell lipid composition in BBB integrity. These findings may usher in new lines of research into how the metabolomic, in addition to the proteomic, signature of CNS endothelial cells regulates BBB function.
Suppression of Caveolae-Mediated Transcytosis Is Essential for BBB Function
Compared to the relatively well-studied mechanisms of clathrinmediated vesicle trafficking, the physiology of caveolae is less understood. Caveolae have multiple putative functions at the plasma membrane, including cell signal transduction, mechanosensation, lipid metabolism, and plasma membrane organization, and their physiological role in different cell types and tissues is not fully clear (Cheng and Nichols, 2016; Parton and del Pozo, 2013) . While endothelial cells in peripheral organs, such as the lung and heart, are enriched in caveolae, and previous studies have demonstrated that caveolae vesicles act as transcytotic carriers in these peripheral organ endothelial cells (Ghitescu et al., 1986; Oh et al., 2007 Oh et al., , 2014 Schubert et al., 2001) , there remains a long-standing debate as to what role, if any, caveolae play in transcytosis. In particular, recent in vitro studies have challenged the notion that caveolae significantly contribute to endocytic or transcytotic flux (Bitsikas et al., 2014; Shvets et al., 2015) . Our genetic rescue experiments demonstrate that the presence of transcytotic caveolae vesicles accounts for BBB leakage in the absence of Mfsd2a, and thus assign a physiological role to caveolae-mediated transcytosis in CNS endothelial cells to regulate BBB permeability. capillaries compared to lung capillaries further points to a direct role of DHA in the suppression of caveolae vesicles. How does DHA inhibit caveolae vesicles? Caveolae formation depends on both Cav-1 and cholesterol (Lingwood and Simons, 2010; Parton and del Pozo, 2013) . Our findings support previous studies that have shown that DHA treatment of human retinal endothelial cells and human umbilical vein endothelial cells resulted in a significant depletion of cholesterol in the membrane as well as the displacement of Cav-1 and several signaling proteins resident in caveolae (Chen et al., 2007; Li et al., 2007) . Moreover, in vivo studies show that feeding mice with omega-3 fatty acid-enriched diet resulted in a concomitant reduction of cholesterol and Cav-1 in mouse colon epithelium . Therefore, it is likely that in CNS endothelial cells, Mfsd2a acts as a lipid flippase (Quek et al., 2016) , transporting phospholipids, including DHA-containing species, from the outer to the inner plasma membrane leaflet. The increased levels of DHA in the inner plasma membrane leaflet subsequently cause the displacement of cholesterol and Cav-1, thereby inhibiting caveolae formation. It is plausible that DHA enrichment in the plasma membranes results in higher membrane fluidity and low membrane curvature that is not favorable for caveolae formation.
In light of the emerging evidence in both the normal and diseased brain that transcytosis represents a major mechanism for BBB function (Armulik et al., 2010; Ben-Zvi et al., 2014; Chow and Gu, 2017; Daneman et al., 2010b; Haley and Lawrence, 2017; Knowland et al., 2014) , our work provides a mechanistic understanding of how transcytotic pathways are suppressed in the CNS to ensure this function. Future studies, including examining the effect of acute removal of Mfsd2a function in adult mice and the effect of dietary manipulation of lipids on transcytosis and BBB permeability, will shed new light on the development of new therapeutic strategies. It has been postulated that Mfsd2a may serve to modulate transcytotic mechanisms in CNS endothelial cells for therapeutic purposes (Betsholtz, 2014; Zhao and Zlokovic, 2014) . By pinpointing the specific transcytotic route that Mfsd2a suppresses, and by illuminating a novel role of membrane lipid metabolism in BBB function, this work may prompt the development of new strategies to deliver drugs to the diseased CNS, potentially via the use of lipid-based biologics to ''de-repress'' the caveolae pathway.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: All animals were treated according to institutional and US National Institutes of Health (NIH) guidelines approved by the International Animal Care and Use Committee (IACUC) at Harvard Medical School.
Cell lines HEK293T (ATCC, #CRL-3216) and bEnd.3 (ATCC, #CRL-2299) cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin in 5% CO 2 at 37 C. Cell lines were obtained directly from ATCC, with no additional cell authentication performed. PANC-1 cells stably transfected with human MFSD2A-GFP (Reiling et al., 2011) were obtained from Dr. David Sabatini and cultured in DMEM supplemented with 10% FBS, 1% penicillin/streptomycin, and 2 mg/ml puromycin in 5% CO 2 at 37 C.
METHOD DETAILS Lipid profiling
Lipids from whole brain, and brain and lung isolated capillary lysates were profiled using liquid chromatography tandem mass spectrometry (LC-MS) method operated on a Nexera X2 U-HPLC (Shimadzu Scientific Instruments) coupled to an Exactive Plus orbitrap MS (Thermo Fisher Scientific). Briefly, tissue samples were homogenized in a weight proportional volume of water (4ml/mg of tissue) using a TissueLyser II (QIAGEN). Equal starting amounts of tissue homogenate were used as starting material for all mass spectrometry. Lipids were extracted from homogenates (10 ml) using 190 ml of isopropanol containing 1,2-didodecanoyl-sn-glycero-3-phosphocholine as an internal standard (Avanti Polar Lipids). After centrifugation (10 min, 10,000 x g, ambient temperature), supernatants (2 ml) were injected directly onto a 100 3 2.1 mm ACQUITY BEH C8 column (1.7 mm; Waters). The column was eluted at a flow rate of 450 mL/min isocratically for 1 min at 80% mobile phase A (95:5:0.1 vol/vol/vol 10 mM ammonium acetate/methanol/formic acid), followed by a linear gradient to 80% mobile-phase B (99.9:0.1 vol/vol methanol/formic acid) over 2 min, a linear gradient to 100% mobile phase B over 7 min, and then 3 min at 100% mobile-phase B. MS analyses were carried out using electrospray ionization in the positive ion mode using full scan analysis over m/z 200-1100 at 70,000 resolution and 3 Hz data acquisition rate. Additional MS settings were: ion spray voltage, 3.0 kV; capillary temperature, 300 C; probe heater temperature, 300 C; sheath gas, 50; sweep gas, 5; and S-lens RF level 60. Raw data were processed using TraceFinder 3.2 software (Thermo Fisher Scientific) to integrate extracted ion chromatograms for approximately 240 lipids characterized by headgroup and total acyl chain carbon and double bound content. For data analysis, all individual lipid levels (integrated peak area) were normalized to internal standard values prior to statistical testing. Average values of integrated peak area were used for comparisons between conditions for each lipid species.
Immunohistochemistry and immunocytochemistry
Mouse tissues were fixed by immersion in 4% PFA/PBS overnight at 4 C, cryopreserved in 30% sucrose, and frozen in TissueTek OCT (Sakura). Tissue sections were blocked with 10% goat serum/5% BSA/PBST (0.5% Triton X-100) and stained overnight at 4 C with the following primary antibodies: a-Mfsd2a (1:200, Cell Signaling Technologies; RRID: AB_2617168), a-PECAM (1:200, BD Biosciences #553370; RRID: AB_394816), a-Claudin-5-488 conjugate (1:300, Thermo Fisher Scientific #352588; RRID: AB_2532189), isolectin B4 Alexa 488 conjugate (1:200, Thermo Fisher Scientific #I21411), followed by corresponding Alexa Fluor-conjugated secondary antibodies (1:1000, Thermo Fisher Scientific). Sections were mounted with ProLong Gold for imaging. bEnd.3 cells were fixed in 4% PFA/PBS for 15 min at room temperature as processed as described above.
BBB permeability assay Postnatal P4-P5 pups were anaesthetized with isoflurane and 10-kDa dextran tetramethylrhodamine (Thermo Fisher Scientific, Cat #D1817, 10 mg/ml, 10 mL per g body weight) was injected into the left heart ventricle with a Hamilton syringe. After five minutes of circulation, brains were dissected and fixed by immersion in 4% PFA/PBS at 4 C overnight, cryopreserved in 30% sucrose, and frozen in TissueTek OCT (Sakura). Sections of 14 mm were collected and co-stained with a-Claudin-5-488 conjugate (1:300, Thermo Fisher Scientific #352588; RRID: AB_2532189) or isolectin B4 Alexa 488 conjugate (1:200, Thermo Fisher Scientific #I21411) to visualize blood vessels. Adult Adult P90 mice were briefly anesthetized with isoflurane and HRP type II (Sigma Aldrich, Cat #P8250-50KU, 0.5 mg/g body weight dissolved in 0.4 mL PBS) was injected bi-laterally into the retro-orbital sinus. After 30 min of circulation, brains were dissected and fixed by immersion in 4%PFA/PBS at 4 C overnight. Following fixation, brains were washed in PBS and forebrain vibratome freefloating sections of 50 mm were collected, processed in a standard DAB reaction for 35 min, and mounted on 3% gelatin-coated slides. Slides were dehydrated through an ethanol series and mounted with Permount for brightfield imaging.
Transmission electron microscopy In vivo
Brains from P4-P5 pups were dissected and fixed by immersion in 5% glutaraldehyde/4% PFA/0.1 M sodium-cacodylate for 10-14 days at room temperature. P90 mice were anaesthetized and HRP type II (Sigma Aldrich, Cat #P8250-50KU, 0.5 mg/g QUANTIFICATION AND STATISTICAL ANALYSIS Quantification of BBB leakage Postnatal dextran tracer permeability assay All quantification was performed blind using a custom ImageJ (NIH) macro (see Data S1). 6-8 images per animal were obtained from 14 mm thick coronal forebrain sections of the same rostrocaudal position using a 40x oil immersion objective. The same forebrain regions were imaged among littermate pairs. The same background subtraction and auto threshold parameters were applied to max z-projections of both Isolectin/Claudin-5 (endothelium vessel markers), and dextran (tracer) channels. Masks of both channels were generated and the permeability index of leakage was defined as the area of tracer mask divided by area of vessels mask. A leakage value of 1 signifies no tracer extravasation, while significantly higher values signify tracer extravasation.
TEM Quantification
For all TEM quantifications, mean vesicular pit/vesicular density values were calculated from the number of vesicles per mm of membrane for each image collected. All images were collected at 12000x magnification. Density values for each cell source/genotype reflect the average of mean density values obtained from each individual experiment/animal and are expressed as mean ± s.e.m.
Statistical Analysis
All statistical analyses were performed using Prism 7 (GraphPad Software). Two group comparisons were analyzed using an unpaired two-tailed Student's t test. Multiple group comparisons were analyzed using a one-way ANOVA, followed by a post hoc Tukey's test. Sample size for all experiments was determined empirically using standards generally employed by the field, and no data was excluded when performing statistical analysis. Standard error of the mean was calculated for all experiments and displayed as errors bars in graphs. Statistical details for specific experiments, including exact n values and what n represents, precision measures, statistical tests used, and definitions of significance can be found in the Figure Legends. 
DATA AND SOFTWARE AVAILABILITY
A custom ImageJ macro was used to quantify postnatal dextran tracer permeability assays, as described in the Method Details. For script, see Data S1.
